Kyong Yeun Jung1, Hwa Young Ahn2, Sun Kyoung Han3, Young Joo Park4, Bo Youn Cho2, Min Kyong Moon5. 1. Department of Internal Medicine, Eulji General Hospital, Seoul, Korea. 2. Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Chung-Ang University, Seoul, Korea. 3. Department of Internal Medicine, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea. 4. Department of Internal Medicine, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea. 5. Department of Internal Medicine, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea. Electronic address: mkmoon@snu.ac.kr.
Abstract
BACKGROUND: Thyroid hormone regulates lipid metabolism. In particular, it has been reported to regulate plasma high-density lipoprotein cholesterol (HDL-C) levels and the activity of molecules involved in HDL metabolism. OBJECTIVE: We investigated changes in the concentrations of lipids and apolipoproteins and in the function of HDL according to acute dynamic changes in thyroid function. METHODS: Concentrations of plasma lipids and apolipoproteins, paraoxonase-1 activity, and cholesterol efflux were measured in 27 patients with differentiated thyroid carcinoma who underwent total thyroidectomy and radioactive iodine (RAI) treatment, at 3 distinct times: After surgery (baseline subclinical hyperthyroid state), on the day of undergoing RAI treatment (overt hypothyroid state), and 3 months post-RAI treatment (subclinical hyperthyroid state). RESULTS: The mean free T4 and thyroid-stimulating hormone concentrations were 0.24 ± 0.06 ng/dL and 91.2 (77.8-118.2) μIU/mL, respectively, on the day of RAI treatment. Total cholesterol, triglyceride, low-density lipoprotein cholesterol, and apoB levels, and the apoA-I/II ratio were significantly increased in the overt hypothyroid state and recovered to baseline values with levothyroxine replacement. HDL-C and apoE levels were persistently elevated despite levothyroxine replacement. Paraoxonase-1 activity, corrected for apoA-I, decreased in the overt hypothyroid state but recovered with levothyroxine replacement (P = .009). Cholesterol efflux also decreased significantly in the overt hypothyroid state (21.5 ± 5.1% vs 18.9 ± 2.9%, P = .005), but remained low despite recovery of thyroid function. CONCLUSION: Changes in thyroid function are associated not only with changes in the concentrations of various plasma lipid components but also with changes in HDL function.
BACKGROUND: Thyroid hormone regulates lipid metabolism. In particular, it has been reported to regulate plasma high-density lipoprotein cholesterol (HDL-C) levels and the activity of molecules involved in HDL metabolism. OBJECTIVE: We investigated changes in the concentrations of lipids and apolipoproteins and in the function of HDL according to acute dynamic changes in thyroid function. METHODS: Concentrations of plasma lipids and apolipoproteins, paraoxonase-1 activity, and cholesterol efflux were measured in 27 patients with differentiated thyroid carcinoma who underwent total thyroidectomy and radioactive iodine (RAI) treatment, at 3 distinct times: After surgery (baseline subclinical hyperthyroid state), on the day of undergoing RAI treatment (overt hypothyroid state), and 3 months post-RAI treatment (subclinical hyperthyroid state). RESULTS: The mean free T4 and thyroid-stimulating hormone concentrations were 0.24 ± 0.06 ng/dL and 91.2 (77.8-118.2) μIU/mL, respectively, on the day of RAI treatment. Total cholesterol, triglyceride, low-density lipoprotein cholesterol, and apoB levels, and the apoA-I/II ratio were significantly increased in the overt hypothyroid state and recovered to baseline values with levothyroxine replacement. HDL-C and apoE levels were persistently elevated despite levothyroxine replacement. Paraoxonase-1 activity, corrected for apoA-I, decreased in the overt hypothyroid state but recovered with levothyroxine replacement (P = .009). Cholesterol efflux also decreased significantly in the overt hypothyroid state (21.5 ± 5.1% vs 18.9 ± 2.9%, P = .005), but remained low despite recovery of thyroid function. CONCLUSION: Changes in thyroid function are associated not only with changes in the concentrations of various plasma lipid components but also with changes in HDL function.
Authors: Rade Vukovic; Aleksandra Zeljkovic; Biljana Bufan; Vesna Spasojevic-Kalimanovska; Tatjana Milenkovic; Jelena Vekic Journal: Front Endocrinol (Lausanne) Date: 2019-12-10 Impact factor: 5.555
Authors: Trynke van der Boom; Congzhuo Jia; Joop D Lefrandt; Margery A Connelly; Thera P Links; Uwe J F Tietge; Robin P F Dullaart Journal: J Clin Endocrinol Metab Date: 2020-09-01 Impact factor: 5.958
Authors: Min-Young Park; Sang Eun Nam; Kyoung Sik Park; Madhuri Saindane; Young-Bum Yoo; Jung-Hyun Yang; Ah-Leum Ahn; Jae-Kyung Choi; Won Seo Park Journal: Ann Surg Treat Res Date: 2019-08-29 Impact factor: 1.859